Rufinamide is an anticonvulsant medication with clinical applications (1). It inhibits Nav1.1 and Nav1.6 activation (2). In gerbils, Rufinamide improved cognitive function and increased neurogenesis by increasing IGF-1, IGF-1R, and p-CREB (3).
1) Hakimian et al. (2007), Rufinamide: a new anti-epileptic medication; Expert Opin.Pharmacother. 8 1931
2) Gilchrist et al. (2014), Nav1.1 Modulation by a Novel Triazole Compound Attenuates Epileptic Seizures in Rodents; ACS Chem.Biol. 9 1204
3) Chen et al. (2018), Rufinamide, an antiepileptic drug, improves cognition and increases neurogenesis in the aged gerbil hippocampal dentate gyrus via increasing expressions of IGF-1, IGF-1R and p-CREB; Chem.Biol.Interact 286 71
- Product Reviews
- Product Publications
If you've used this product in a publication, let us know. Email email@example.com, with the publication details and you could be eligible for an Amazon gift card.
- Related Products